

CLASSIFICATION: DHT-DERIVED ANDROGEN (ORAL)
ACTIVE SUBSTANCE: MESTEROLONE
FORM: 20 TABLETS x 25 MG
ACTIVE HALF-LIFE: ~12–13 HOURS
DOSAGE: MEN 25-100 MG/DAY
ACNE: POSSIBLE
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): NOT TYPICAL
HEPATOTOXICITY: LOW
AROMATIZATION: NONE
MANUFACTURER: BAYER SCHERING
Proviron contains mesterolone, a DHT-derived oral androgen historically prescribed for androgen deficiency and select male fertility evaluations. In performance settings, it is widely discussed for its ability to provide a "dry," cosmetic look and to support libido during protocols that otherwise suppress androgen tone. As a prescription androgen, Proviron must be used only under licensed medical supervision and within applicable laws.
Mesterolone is structurally related to dihydrotestosterone (DHT). It does not aromatize to estrogen and is traditionally leveraged where a lean, tight look is desired. Unlike heavy bulking orals, Proviron's goal is not dramatic weight change; instead, users often describe improved muscle density, hardness, and sexual wellbeing when a clinician deems it appropriate. It is also known for a pronounced interaction with sex hormone–binding globulin (SHBG) — a protein that binds circulating androgens — which can influence the balance between total and free testosterone during a cycle.
Country-specific labeling has historically included a commencement phase of 25 mg three times daily, followed by 25 mg once or twice daily for continuation/maintenance, with the exact schedule individualized by a clinician. The optimal dose and duration depend on clinical goals, age, and cardiovascular risk profile. Because mesterolone has an approximate terminal half-life of 12–13 hours, split dosing can provide stable exposure across the day.
For authoritative component pharmacology and labeled dosing examples, see the Bayer Proviron Summary of Product Characteristics.
Potential positives when indicated: crisper, drier look (non-aromatizing); firmer muscle tone; libido support; synergy with other androgens by modulating SHBG dynamics. Potential downsides: androgenic effects (acne, scalp shedding in predisposed individuals), possible adverse lipid changes over time, and—like all androgens—risk considerations for the prostate in susceptible populations. Proviron is not a "free pass": the best outcomes pair conservative dosing with labs and smart cycle design.
Because Proviron doesn't convert to estrogen, it's commonly positioned as a finishing agent in advanced recomposition/cutting phases or as libido support when aromatizable bases are reduced. It's not a substitute for cycle fundamentals: sane dosing, sensible durations, and peri-cycle bloodwork. If your protocol uses aromatizable testosterone or powerful 19-nor compounds, adjust the rest of the stack first; don't rely on Proviron to "fix" a mismatched plan.
Depending on lab-guided goals, athletes sometimes pair Proviron with low-to-moderate androgen backbones to polish a look or maintain mood/drive:
Unlike methylated bulking orals used for aggressive mass phases, Proviron is not a classic 17-alpha-alkylated steroid. Nevertheless, all androgens warrant respect: rare hepatic events have been reported with androgen therapy in general, and long-term or multi-oral stacks amplify risk. Monitor LFTs when cycles include more than one oral agent, avoid alcohol, and follow your clinician's duration limits. Cardiometabolic oversight (lipids, blood pressure, hematology) is equally important in longer programs.
This listing is for genuine Bayer Schering Proviron 25 mg tablets (20 count). Store at room temperature away from moisture and heat. Keep out of reach of children. Use only as prescribed and dispensed legally in your jurisdiction.
Medical & legal disclaimer: This information is educational and not medical advice. Prescription androgens must be used under a licensed clinician's supervision and in accordance with local laws.
No. Mesterolone does not convert to estrogen, so it does not promote estrogen-related water retention. Many users choose it for a "dry" cosmetic finish when clinically appropriate.
Labeling in various markets has used 25 mg three times daily to start, then 25 mg once or twice daily for continuation. Your clinician individualizes the schedule and duration for your case.
Compared with 17-alpha-alkylated bulking orals, Proviron is generally considered to have a lower hepatic burden. Still, all androgens warrant care—use conservative durations and follow your provider's lab plan.
The terminal half-life is roughly 12–13 hours. Many users split morning/evening dosing for steadier levels, but follow your prescriber's instructions.
No. Proviron is an androgen; it neither serves as a SERM-based PCT nor functions like an aromatase inhibitor when estradiol is objectively high. It complements a balanced, lab-guided plan.
Please log in to write Proviron review.
CLASSIFICATION: ANDROGEN; ANABOLIC STEROID
ACTIVE SUBSTANCE: MESTEROLONE
FORM: 100 PILLS x 25 MG
ACTIVE HALF-LIFE: 12 HOURS
DOSAGE: MEN 25-100 MG/DAY
ACNE: YES
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: LOW
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
CLASSIFICATION: ANDROGEN; ANABOLIC STEROID
ACTIVE SUBSTANCE: MESTEROLONE
FORM: 30 PILLS x 25 MG
ACTIVE HALF-LIFE: 12 HOURS
DOSAGE: MEN 25-100 MG/DAY
ACNE: YES
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: LOW
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS